Sign Up to like & get
recommendations!
0
Published in 2020 at "Neuropharmacology"
DOI: 10.1016/j.neuropharm.2020.108195
Abstract: Novel synthetic opioids are appearing in recreational drug markets worldwide as adulterants in heroin or ingredients in counterfeit analgesic medications. 3,4-Dichloro-N-[(1R,2R)-2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700) is an example of a non-fentanyl synthetic opioid linked to overdose deaths. Here,…
read more here.
Keywords:
opioid 47700;
novel synthetic;
pharmacokinetics novel;
pharmacodynamics pharmacokinetics ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Journal of Pharmacology and Pharmacotherapeutics"
DOI: 10.1177/0976500x221111669
Abstract: Objectives To evaluate the pharmacokinetics of a novel sustained-release oral tablet (C-Fence, Inventia Healthcare Limited, Mumbai, India). Methods We conducted a randomized, placebo-controlled, parallel-design, 500 mg single-dose pharmacokinetic study of this new preparation in 18…
read more here.
Keywords:
placebo controlled;
novel sustained;
oral tablet;
sustained release ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2023 at "Protein and peptide letters"
DOI: 10.2174/0929866530666230217112942
Abstract: Protein and peptide drugs have been considered to be valuable for treating disease for many years, capturing more and more of the attention of researchers. Previously, we found a short peptide from the porcine intestine…
read more here.
Keywords:
oral cyclic;
cyclic peptide;
novel oral;
pharmacokinetics novel ... See more keywords